TABLE 2.
Treatment | Year | Author | Period (month) | Patient (n) | Control (n) | Character of Control | PU | GIF |
---|---|---|---|---|---|---|---|---|
CAPD | ||||||||
1995 | De Vecchi AF (21) | NA | 53% (38)a | 79% (38) | Symptoms | + | − | |
1997 | Antoniou S (49) | (1–108) | 64% (39) | NA | NA | − | ||
2001 | Aguilera A (50) | 18 ± 13 | 33% (48) | NA | − | − | ||
2005 | Lui SL (51) | 54 ± 42 | 26% (136) | NA | NA | − | ||
2008 | Altay M (52) | 21 ± 18 | 27% (64) | NA | NA | − | ||
TX | ||||||||
1991 | Davenport A (18) | 45 (6–219) | 29% (202) | 30% (247) | Healthy | NA | − | |
1997 | Hruby Z (26) | 41 ± 35 | 62% (29) | 44% (16) | Dyspepsia | NA | + | |
1997 | Ozgur O (27) | 51 ± 40 | 70% (54) | 64% (100) | Symptoms | + | + | |
1999 | Yildiz A (29) | 38.6% (57) | 73% (55) | Healthy | NA | − | ||
2007 | Khedmat H (9) | 52 ± 16 | 40% (25) | 35% (305) | Dyspepsia | + | + | |
CRF | ||||||||
1990 | Shousha S (53) | 24% (50)a | 42% (120) | Symptoms | − | + | ||
1991 | Ala-Kaila K (54) | 17% (89) | NA | NA | − | |||
1993 | Neithercut WD (55) | 48% (23) | NA | NA | + | |||
1995 | Jaspcrson D (20) | 24% (59)a | 37% (127) | Symptoms | + | + | ||
1997 | Moustafa FE (56) | 40% (70) | NA | NA | + | |||
1999 | Misra V (57) | 56% (50)a | 78% (50) | Healthy | − | + | ||
2000 | Emir S (58) | 63% (16) | NA | + | + | |||
2002 | Schoonjans R (59) | 46% (28) | NA | − | − | |||
2004 | Strid H (60) | 26% (31) | NA | NA | − | |||
2004 | Nakajima F (41) | 53.3 (30) | 62% (138) | Healthy | NA | − | ||
2007 | Khedmat H (9) | 66% (71)b | 35% (305) | Dyspepsia | + | + |
P < 0.05 when significantly lower compared with control subjects;
P < 0.05 when significantly higher compared with control subjects.
Treatment period was determined as median (range) or mean ± SE or SD according to reports. Gastrointestinal endoscopy (GIF)-positive (+) indicates that GIF was performed in the study, and peptic ulcer-positive (+) meant reports included peptic ulcer in both/either patient group and/or control group with normal renal function. CAPD, continuous ambulatory peritoneal dialysis; CRF, chronic renal failure; PU, peptic ulcer; NA, not available; Tx, kidney transplant.